Literature DB >> 15531106

Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity.

Jens Weise1, Olaf Crome, Raoul Sandau, Walter Schulz-Schaeffer, Mathias Bähr, Inga Zerr.   

Abstract

The pathological isoform of the prion protein (PrP(Sc)) has been identified to mediate transmissible spongiform encephalopathies like Creutzfeldt-Jakob disease (CJD). In contrast, the physiological function of the normal cellular prion protein (PrP(c)) is not yet understood. Recent findings suggest that PrP(c) may have neuroprotective properties and that its absence increases susceptibility to oxidative stress and neuronal injury. To determine whether PrP(c) is part of the cellular response to neuronal injury in vivo, we investigated PrP(c) regulation after severe and mild focal ischemic brain injury in mice using the thread occlusion stroke model. Western Blot and ELISA analysis showed a significant upregulation of PrP(c) in the ischemic hemisphere at 4 and 8h after onset of permanent focal ischemia, which was no longer detectable at 24h after lesion induction when compared to control animals. In contrast, transient focal ischemia (60 min) did only lead to slightly but not significantly elevated PrP(c) levels in the ischemic hemisphere when compared to controls. These results demonstrate that cerebral PrP(c) is upregulated early in response to focal cerebral ischemia. The extent of upregulation, however, seems to depend on the severity of ischemia and may therefore reflect the extent of ischemia induced neuronal damage. Given the known neuroprotective effects of PrP(c) in vitro, ischemia-induced upregulation of cerebral PrP(c) supports the hypothesis that, as part of an early adaptive cellular response to ischemic brain injury, PrP(c) may be involved in the regulation of ischemia-induced neuronal cell death in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531106     DOI: 10.1016/j.neulet.2004.09.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  50 in total

1.  PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Susan Morgello; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Cellular prion protein (PrP(C)) and its role in stress responses.

Authors:  Liang Zeng; Wenquan Zou; Gongxian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC).

Authors:  Raymond Yen-Yu Lo; Woei-Cherng Shyu; Shinn-Zong Lin; Hsiao-Jung Wang; Shun-Sheng Chen; Hung Li
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

4.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

Review 5.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 6.  Is, indeed, the prion protein a Harlequin servant of "many" masters?

Authors:  M Catia Sorgato; Caterina Peggion; Alessandro Bertoli
Journal:  Prion       Date:  2009-10-04       Impact factor: 3.931

7.  Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex.

Authors:  Anatoly Uzdensky; Svetlana Demyanenko; Grigory Fedorenko; Tayana Lapteva; Alexej Fedorenko
Journal:  Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.590

8.  Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Authors:  Daisuke Yoshikawa; Naohiro Yamaguchi; Daisuke Ishibashi; Hitoki Yamanaka; Nobuhiko Okimura; Yoshitaka Yamaguchi; Tsuyoshi Mori; Hironori Miyata; Kazuto Shigematsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

Review 9.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

Review 10.  Cellular prion protein null mice display normal AMPA receptor mediated long term depression.

Authors:  Houman Khosravani; Yunfeng Zhang; Gerald W Zamponi
Journal:  Prion       Date:  2008-04-16       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.